HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,128,505 | -73.5% | 156,500 | -71.5% | 0.00% | -66.7% |
| Q2 2023 | $19,336,905 | +122510.5% | 549,500 | +13.8% | 0.01% | 0.0% |
| Q1 2023 | $15,771 | +53.1% | 483,032 | +158.4% | 0.01% | +80.0% |
| Q4 2022 | $10,299 | -99.2% | 186,930 | +568.7% | 0.01% | +400.0% |
| Q3 2022 | $1,238,000 | +73.4% | 27,954 | +90.4% | 0.00% | – |
| Q1 2022 | $714,000 | +62.3% | 14,683 | +42.2% | 0.00% | – |
| Q4 2021 | $440,000 | -78.6% | 10,329 | -80.8% | 0.00% | -100.0% |
| Q3 2021 | $2,057,000 | -51.1% | 53,662 | -64.0% | 0.00% | -66.7% |
| Q2 2021 | $4,204,000 | +1561.7% | 148,923 | +1845.9% | 0.00% | – |
| Q1 2021 | $253,000 | -95.2% | 7,653 | -94.7% | 0.00% | -100.0% |
| Q4 2020 | $5,230,000 | -62.8% | 144,663 | -65.1% | 0.00% | -76.5% |
| Q3 2020 | $14,044,000 | – | 414,287 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $618,113,619 | 97.50% |
| venBio Partners LLC | 1,035,396 | $57,050,320 | 17.69% |
| Vivo Capital, LLC | 2,606,247 | $143,604 | 16.53% |
| Nan Fung Group Holdings Ltd | 368,665 | $20,313,442 | 14.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $14,560,725 | 4.50% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 685,340 | $37,762,234 | 3.51% |
| ASHFORD CAPITAL MANAGEMENT INC | 356,638 | $19,650,754 | 3.05% |
| TANG CAPITAL MANAGEMENT LLC | 281,200 | $15,494,120 | 2.25% |
| MPM BioImpact LLC | 139,377 | $7,679,673 | 1.99% |
| O'Neil Global Advisors, Inc. | 7,335 | $404 | 1.86% |